You are here: Industry Insights > Covishield

News List

Government gives nod to commercial export of Covishield and Covaxin in view of sufficient stock ExpressPharma
November 29, 2021
The Union government has allowed commercial export of Covishield and Covaxin considering the sufficient stock of the COVID-19 vaccines available with states and Union Territories as well as with manufacturers, official sources told PTI recently.
SII urges govt to fast-track movement of increasing Covishield stock ExpressPharma
November 24, 2021
The Serum Institute of India (SII) has urged the government to fast-track Covishield movement citing the difficulties being faced in production and cold chain space planning for other vaccines...
Government allows Serum Institute to export 50 lakh Covishield doses under COVAX to four nations ExpressPharma
November 23, 2021
The Union government has allowed the Serum Institute of India (SII) to export 50 lakh doses of COVID-19 vaccine Covishield under the UN-backed COVAX global vaccine programme to Nepal, Tajikistan and Mozambique, official sources said.
CDSCO approves study on mixing of Covaxin and Covishield doses expresspharma
August 13, 2021
"The aim of the study is to assess the feasibility on whether a person can be given two different vaccine shots -- one each of Covishield and Covaxin -- to complete the inoculation course," a source said.
ICMR says Covaxin-Covishield combination shows better results expresspharma
August 10, 2021
The Indian Council of Medical Research (ICMR), in its recent study, mentioned that mixing and matching of COVID-19 vaccines, namely Covaxin and Covishield, showed better results.
Monthly production capacity of Covishield projected to increase to 120 million doses, Covaxin to 58 million doses: Minister expresspharma
August 05, 2021
The monthly production capacity of Covishield is projected to be increased to more than 120 million doses, and of Covaxin to around 58 million doses by December, the government told Rajya Sabha August 3, citing information from the COVID-19 vaccine ...
Covishield single-dose efficacy drops after 16 weeks in people above 60 years: Sri Lankan research expresspharma
August 02, 2021
The efficacy of the single dose of Covishield dropped at 16 weeks for those above the age of 60, while 93 per cent of the younger population showed good responses during the same duration, a university research in Colombo has shown.
Covishield gives 93 per cent protection against COVID and 98 per cent mortality reduction: AFMC expresspharma
July 30, 2021
Addressing a press conference, Dr V K Paul, Member (Health), NITI Aayog, presented findings of the study which was conducted on 15 lakh doctors and frontline workers.
Only marginal difference in purchase price of Covishield and Covaxin for Centre: MoS Health expresspharma
July 27, 2021
The Government of India has been supplying vaccines free of cost to the states/UTs for administration to prioritised beneficiaries as recommended by NEGVAC.
Centre to buy Covishield and Covaxin at revised rates expresspharma
July 20, 2021
The price of each dose of Covishield amounts to Rs 215.25, and Covaxin Rs 225.75, including taxes.

Previous page 1 2 3 4 5 Next page